Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatem A Azim

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 19, 2015
Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'Oranite Goldrat, Isabelle Demeestere, Hatem A Azim
Targeted Oncology|June 22, 2010
Targeting mTOR in cancer: renal cell is just a beginningHamdy Azim, Hatem A Azim, Bernard Escudier
Cancer Treatment Reviews|July 31, 2009
Trastuzumab versus lapatinib: the cardiac side of the storyHamdy Azim, Hatem A Azim, Bernard Escudier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2009
Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancyHatem A Azim, Giovanna Scarfone, Fedro A Peccatori
Cancer Treatment Reviews|March 22, 2015
Targeted agents for cancer treatment during pregnancyMatteo Lambertini, Fedro A Peccatori, Hatem A Azim
Expert Review of Anticancer Therapy|September 2, 2016
What is the role of informed decision-making?Noam Pondé, Lissandra Dal Lago, Hatem A Azim
Expert Review of Clinical Immunology|October 29, 2010
Treatment of cancer during pregnancy with monoclonal antibodies: a real challengeHatem A Azim, Hamdy Azim, Fedro A Peccatori
Cancer Treatment Reviews|December 18, 2009
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumorsHatem A Azim, Fedro A Peccatori, Nicholas Pavlidis
Lung Cancer (Amsterdam, Netherlands)|November 10, 2009
Lung cancer in the pregnant woman: to treat or not to treat, that is the questionHatem A Azim, Fedro A Peccatori, Nicholas Pavlidis
Cancer Treatment Reviews|December 19, 2009
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumorsHatem A Azim, Nicholas Pavlidis, Fedro A Peccatori
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|December 19, 2015
Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'Oranite Goldrat, Isabelle Demeestere, Hatem A Azim
Targeted Oncology|June 22, 2010
Targeting mTOR in cancer: renal cell is just a beginningHamdy Azim, Hatem A Azim, Bernard Escudier
Cancer Treatment Reviews|July 31, 2009
Trastuzumab versus lapatinib: the cardiac side of the storyHamdy Azim, Hatem A Azim, Bernard Escudier
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 1, 2009
Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancyHatem A Azim, Giovanna Scarfone, Fedro A Peccatori
Cancer Treatment Reviews|March 22, 2015
Targeted agents for cancer treatment during pregnancyMatteo Lambertini, Fedro A Peccatori, Hatem A Azim
Expert Review of Anticancer Therapy|September 2, 2016
What is the role of informed decision-making?Noam Pondé, Lissandra Dal Lago, Hatem A Azim
Expert Review of Clinical Immunology|October 29, 2010
Treatment of cancer during pregnancy with monoclonal antibodies: a real challengeHatem A Azim, Hamdy Azim, Fedro A Peccatori
Cancer Treatment Reviews|December 18, 2009
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumorsHatem A Azim, Fedro A Peccatori, Nicholas Pavlidis
Lung Cancer (Amsterdam, Netherlands)|November 10, 2009
Lung cancer in the pregnant woman: to treat or not to treat, that is the questionHatem A Azim, Fedro A Peccatori, Nicholas Pavlidis
Cancer Treatment Reviews|December 19, 2009
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumorsHatem A Azim, Nicholas Pavlidis, Fedro A Peccatori
Pageof 14